Financials
- Market Capitalization 153.7 M
- Employee 29
- Founded 2015
- CEO N/A
- Website nrxpharma.com
- Headquarter Delaware, United States
- FIGI BBG00JCWDN63
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-2.03
Rapporto prezzo/fatturato
47.35
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 3735 | OTLK Outlook Therapeutics, Inc. - Common Stock | 0.64 USD | 0.00% | +3.23% | -37.25% | +55.15% | 155.81 M USD | ||
| 3740 | TNYA Tenaya Therapeutics, Inc. - Common Stock | 0.69 USD | -1.43% | -1.43% | -5.48% | -38.39% | 154.72 M USD | ||
| 3748 | INDP Indaptus Therapeutics, Inc. - Common Stock | 1.14 USD | -1.72% | -8.06% | -36.67% | -40.00% | 151.90 M USD | ||
| 3751 | EQ Equillium, Inc. - Common Stock | 2.39 USD | -2.45% | +4.37% | +4.37% | +43.11% | 151.55 M USD |